- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Infographic: A Look Back at Healthcare Steps in Trump's First 100 Days
In the first 100 days of his administration, President Donald J. Trump has taken a number of actions that could impact healthcare, including filling a Supreme Court seat and taking steps to repeal the Affordable Care Act. Here's a look back at some of the most notable healthcare-related happenings in Trump's first 100 days in office.
When President Donald Trump was inaugurated on January 20, he signed an executive order that same day signaling his intentions to repeal the Affordable Care Act, which was one of his major campaign promises. During his first 100 days in office, he filled several key healthcare positions in the government and appointed a justice to the Supreme Court, which could have long-lasting impacts on health issues in America.
Trump and his administration have also been confronted with some difficult choices on healthcare, like whether to continue funding cost-sharing subsidies and how to stabilize the insurance market. For more on the most significant healthcare-related happenings during Trump’s first 100 days in office, see the infographic below.
AI Meets Medicare: Inside CMS’ WISeR Model With Sanjay Doddamani, MD, MBA
July 17th 2025Sanjay Doddamani, MD, MBA, a former senior advisor to the Center for Medicare and Medicaid Innovation, and internist and cardiologist by training, explains how the Wasteful and Inappropriate Service Reduction (WISeR) Model hopes to work, and addresses concerns about delays and denials from revamped prior authorization processes.
Read More
MFN Drug Pricing: Risks to Access, Affordability, and Innovation in Health Care
July 16th 2025Adam Colborn, JD, associate vice president of congressional affairs at AMCP, shares insights on the impact of the Most Favored Nation drug pricing order when it comes to access, affordability, and innovations in US health care.
Read More
Dupilumab Shows Strong Efficacy in SCORAD-Based AD Assessment
July 14th 2025With few real-life studies that have specifically focused on how atopic dermatitis (AD) affects patients living with the chronic inflammatory skin condition in Latin American countries, the present authors investigated dupilumab-related outcomes among 100 patients using SCORing Atopic Dermatitis (SCORAD) index values.
Read More
